Hepatitis C Patent Falls for Non-Enablement, Wiping Out $2.5 Billion Infringement Verdict

Published date09 March 2018
Law FirmPatterson Belknap Webb & Tyler LLP
AuthorIrena Royzman,Dorothy Leray
Subject MatterPatents,Merck,Patent Litigation,Pharmaceutical Patents,Enablement Inquiries,Written Descriptions,Patent Infringement,Judgment As A Matter Of Law,Intellectual Property Protection,Patent Invalidity,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT